Table 1: The influence of i.p. administration of SLENU on sGPT and sGOT liver transaminases in BLM, DOX, and R-treated mice.

CompoundsGOT (U/L)sGPT (U/L)

Controls (health)
Controls (tumor)
BLM (60 mg/kg)
DOX (60 mg/kg)
R
SLENU (100 mg/kg)
BLM (60 mg/kg) + SLENU (100 mg/kg)
DOX (60 mg/kg) + SLENU (100 mg/kg)
R (60 mg/kg) + SLENU (100 mg/kg)

Data are expressed as mean ± SE; * versus tumor controls; # versus corresponding DOX or R-treated mice.